BioMark Diagnostics Inc.

About BioMark Diagnostics Inc.

BioMark Diagnostics is dedicated to leading the world in early-stage cancer detection. Their mission is to provide universal access to a new paradigm in cancer diagnostics using metabolomics, offering better detection, monitoring, and screening solutions for hard-to-detect cancers through liquid biopsy technology.

Products & Services

Liquid Biopsy SSAT1 Assay:A diagnostic tool for early-stage cancer detection.

Liquid Biopsy Metabolic Panel:A panel for detecting cancer through metabolic biomarkers.

BioMark Technology:A state-of-the-art platform using metabolomics for early cancer detection and treatment.

Specialties

Early Stage Cancer Detection Metabolomics Liquid Biopsy Technology Artificial Intelligence and Machine Learning in Cancer Research Biomarkers

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Non-dilutive funding T: - FT: Non-dilutive funding	A: 185900 MR: - FA: CAD $185,900 FAN: 185900	D: 2023-02-07 FD: 2023-02-07	2 investors

Non-dilutive funding Latest

2023-02-07

$186K

2 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

R

Rashid Ahmed Bux

Founder, Chief Executive Officer

D

Dr. Jeff Haince

Chief Scientific Officer and GM

D

Dr. Bram Ramjiawan

Clinical Trial and Regulatory Expertise

B

Brian Cheng

Chief Technical Officer

G

Gina Huang

CFO and Project Director

D

Dr. Daniel Sitar

Principal Scientific Advisor / Professor Emeritus

View 16 more team members with Pro

Unlock Full Team Directory

Recent News